Cancer vaccines, dendritic cells as therapeutic agents

Guests: Jeffrey Abbey, Dr. Charles Nicolette, Argos Therapeutics, Durham, NC

Jeffrey Abbey, MBA, JD, Vice President, Business Development, Argos Therapeutics
Charles Nicolette, Ph.D., Vice President, Research and Development, Argos Therapeutics

Argos Therapeutics, Inc.

Click to Download: Radio In Vivo April 5, 2006


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s